Warner Chilcott News

Warner Chilcott plc today announced that its subsidiary Warner Chilcott Corporation has commenced a cash tender offer, on the terms and subject to the conditions set forth in the Company's Offer to Purchase and Consent Solicitation Statement dated December 15, 2009 , for any and all of its outstanding 8.75% senior subordinated notes due 2015 .

On Friday's "Stop Trading!" segment on CNBC , Jim Cramer offered up a new thesis: "There's a secular trend away from Dell toward Apple ," he said, with young people in high school and college making the switch.

Warner Chilcott plc today announced the pricing of its previously announced secondary offering of 20,000,000 of its ordinary shares at a price to the public of $22.25 per share.

ARDEE,A Ireland Several holders of Warner Chilcott stock will sell several million of its ordinary shares, the drug maker announced Friday.

Closes sales of pharma unit and puts $3 billion in its coffers. Is Procter & Gamble ready to go on a spending spree? Could be, especially now that its flush with cash.

Warner Chilcott has completed the acquisition of Procter & Gamble's global pharmaceutical business, it said today.

Week of Oct. 26, 2009: OXiGENE to Acquire VaxGen; Warner Chilcott Appoints Global R&D President; More... Oct 28, 2009 Company Notes AnC Bio Inc.

Warner Chilcott plc announced today that Dr. Mahdi Fawzi has joined the company as President, Global Research and Development.

PHARMACEUTICAL giant Warner Chilcott will today seek entry into the fast-track Commercial Court as it completes its corporate migration back home from Bermuda to Ireland , writes Dearbhail McDonald .

International report - Leo Pharma, Denmark, is paying $1 billion in cash to reacquire U.S. rights held by Warner Chilcott for the company's psoriasis portfolio and dermatology pipeline, Pharma Times reports.

A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 09/23/09, Warner Chilcott plc , and LEO Pharma announced, in exchange for a one-time cash payment of $1.0 billion to Warner Chilcott, LEO Pharma is re-acquiring Warner Chilcott's exclusive product licensing rights in the United States to its ...

For the second time in a month, Davis Polk & Wardwell represented Irish drugmaker Warner Chilcott in a billion-dollar deal.

Warner Chilcott plc and LEO Pharma announced today that, in exchange for a one-time cash payment of $1.0 billion to Warner Chilcott, LEO Pharma is re-acquiring Warner Chilcott's exclusive product licensing rights in the United States to its topical psoriasis treatments TaclonexA , Taclonex ScalpA , DovonexA as well as rights to all products in ...

ARDEE,A Ireland Drug maker Warner Chilcott is asking a Delaware judge to uphold its patent on two of its drugs.

Japanese drug company Dainippon Sumitomo Pharma Co. is acquiring U.S. drug maker Sepracor Inc.

After struggling to gain a toehold in the pharmaceutical business, Procter & Gamble has finally decided to give up.

Drug maker Warner Chilcott PLC could announce a $3 billion takeover of Procter & Gamble Co.'s prescription drug business as early as Monday, The Wall Street Journal has reported, citing unidentified people familiar with the deal.

Jim Chanos, one of the world's best-known and most successful short sellers, who made a fortune betting against banks and brokers, said yesterday that he was targeting big pharmaceuticals companies.

By Daniel M. Harrison Private equity firms look like they are about to get a sweet deal, judging by the expected loosening of the FDIC rules on private capital investment in small, distressed banks and the fact that bigger banks seem more than willing to lend to them.

Sells unit to Warner Chilcott for an up-front cash payment of $3.1 billion. Procter & Gamble has sold its pharmaceutical unit to Warner Chilcott, a specialty pharmaceutical company based in Ireland,for $3.1 billion.